Triggering of ovulation in human menopausal gonadotrophin-stimulated cycles: Comparison between intravenously administered gonadotrophin-releasing hormone (100 and 500 μg), GnRH agonist (buserelin, 500 μg) and human chorionic gonadotrophin (10 000 IU)

Human Reproduction

Volumn 10, Issue 1, 1995, Pages 56-62

  Gerris, J ^a   Devits, A ^b   Joostens, M ^b   Van Royen, E ^a  

^a MIDDELHEIM HOSPITAL   (Belgium)

^b NONE

Author keywords

Endogenous LH surge; GnRH; GnRH agonist; Luteal insufficiency; OHSS

Indexed keywords

BUSERELIN; CHORIONIC GONADOTROPIN; ESTRADIOL; FOLLITROPIN; GONADORELIN; LUTEINIZING HORMONE; PROGESTERONE;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; ESTRADIOL BLOOD LEVEL; FEMALE; FOLLITROPIN BLOOD LEVEL; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUTEAL INSUFFICIENCY; LUTEAL PHASE; LUTEINIZING HORMONE BLOOD LEVEL; LUTEINIZING HORMONE RELEASE; ORAL DRUG ADMINISTRATION; OVARY DISEASE; OVULATION INDUCTION; PROGESTERONE BLOOD LEVEL;

EID: 0028938622     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/10.1.56     Document Type: Article

References (29)

1. Balasch, J., Tur, R., Creus, M., Buxaderes, R., Fabregues, F., Ballesca, J. L., Barri, P. N., Vanrell, J. A. (1994) Triggering of ovulation by a gonadotropin releasing hormone agonist in gonadotropin-stimulated cycles for prevention of ovarian hyperstimulation syndome and multiple pregnancy. Gynecol. Endocrinol., 8, 7-12.
2. Belaisch-Allart, J., Belaisch, J., Hazout, A., Testart, J. and Frydman, R. Selective oocyte retrieval: a new approach to ovarian hyperstimulation. Fertil. Steril., 50, 654-656.
3. Bentick, B., Shaw, R.W., Iffland, C.A., Burford, G. and Bernard, A. IVF pregnancy after induction of an ovulatory endogenous gonadotrophin surge using an LHRH agonist nasal spray. Hum. Reprod., 5, 570-572.
4. Bergh, P.A. and Navot, D. (1992) Ovarian hyperstimulation syndrome: a review of pathophysiology. J. In Vitro Fertil. Embryo Transfer, 9, 429-438.
5. Blankstein, J., Shalev, J., Saadou, T., Kukia, E.E., Rabinovici, J., Pariente, C., Lunenfeld, B., Serr, D.M. and Mashiach, S. (1987) Ovarian hyperstimulation syndrome: prediction by number and size of preovulatory ovarian follicles. Fertil. Steril., 47, 597-602.
6. Cohlen, B.J., Reinte Velde, E., Scheffer, G., Van Kooij, R.J., De Brouwer, C.P.M. and Van Zonneveld, P. (1993) The pattern of the luteinizing hormone surge in spontaneous cycles is related to the probability of conception. Fertil. Steril., 60, 413-417.
7. Corson, S.L., Batzer, F.R., Gocial, B. and Maislin, G. (1993) The luteal phase after ovulation induction with human menopausal gonadotropin and one versus two doses of a gonadotropin-releasing hormone agonist. Fertil. Steril., 59, 1251-1256.
8. Damewood, M.D., Shen, W., Zacur, H.A., Schlaff, W.D., Rock, J.A. and Wallach, E.E. (1989) Disappearance of exogeneously administered human chorionic gonadotropin. Fertil. Steril., 52, 398-400.
9. Delvigne, A., Demoulin, A., Smitz, J., Donnez, J., Koninckx, Ph., Dhont, M., Englert, Y., Delbeke, L., Darcis, L., Gordts, S., Puttemans, P., Gerris, J., Schoysman, R. and Leroy, F. (1993) The ovarian hyperstimulation syndrome in in-vitro fertilization: a Belgian multicentric study. I. Clinical and biological features. Hum. Reprod., 8, 1353-1360.
10. Emperaire, J.-C. and Ruffle, A. (1991) Triggering of ovulation with endogeneous luteinizing hormone may prevent the ovarian hyperstimulation syndrome. Hum. Reprod., 6, 506-510.
11. Eppig, J.J. (1979) FSH stimulates hyaluronic acid synthesis by oocyte- cumulus cell complexes from mouse preovulatory follicles. Nature, 281, 483-484.
12. Gonen, Y., Balakier, H., Powell, W. and Casper, R.F. (1990) Use of gonadotropin-releasing hormone agonist to trigger follicular maturation for in vitro fertilization. J. Clin. Endocrinol. Metab., 71, 918-922.
13. Haning, R.V., Strawn, E.Y. and Nolten, W.E. (1985) Pathophysiology of the ovarian hyperstimulation syndrome. Obstet. Gynecol., 66, 220-224.
14. Hotchkiss, J. and Knobil, E. (1994) The menstrual cycle and its neuroendocrine control. In Knobil, E. and Neill, J.D. (eds), The Physiology of Reproduction, 2nd edn. Raven Press, New York, pp. 711-749.
15. Imoehdeme, D.A.G., Signe, A.B., Pacpaco, E.L.A., Olazo, A.B. Stimulation of endogeneous surge of luteinizing hormone with gonadotropin-releasing hormone analog after ovarian stimulation for in vitro fertilization. Fertil. Steril., 55, 328-332.
16. Itskovitz, J., Boldes, R., Levron, J., Erlik, Y., Kahana, L. and Brandes, J.M. (1991) Induction of preovulatory luteinizing hormone surge and prevention of ovarian hyperstimulation syndrome by gonadotropin-releasing hormone agonist. Fertil. Steril., 56, 213-220.
17. Kushnir, O., Ben-Rafael, Z., Shalev, J., Lipitz, S., Bider, D., Mashiach, S. and Blankstein, J. (1991) Hormonal profiles and follicular growth in cycles with imminent ovarian hyperstimulation. Hum. Reprod., 6, 665-669.
18. Lanzone, A., Fulghesu, A.M., Apa, R., Caruso, A. and Mancuso, S. LH surge induction by GnRH-agonist at the time of ovulation. Gynecol. Endocrinol., 3, 213-220.
19. Lemay, A., Faure, N., Labrie, F. and Fazekas, A. T. A. (1983) Gonadotroph and corpus luteum responses to two successive intranasal doses of a luteinizing hormone-releasing hormone agonist at different days after the midcycle luteinizing hormone surge. Fertil. Steril., 39, 661-667.
20. Lessing, J.B., Amit, A., Libal, Y., Yovel, I., Kogosowki, A. and Peyser, M.R. (1991) Avoidance of cancellation of potential hyperstimulation cycles by conversion to in vitro fertilization-embryo transfer. Fertil. Steril., 56, 75-78.
21. Rizk, B. and Smitz, J. (1992) Ovarian hyperstimulation syndrome after superovulation using GnRH-agonists for IVF and related procedures. Hum. Reprod., 7, 320-327.
22. Schoot, D., Pache, T.D., Hop, W.C., De Jong, F.H. and Fauser, B. C. J. M. Growth pattern of ovarian follicles during induction of ovulation with decreasing doses of human menopausal gonadotropin following presumed selection in polycystic ovary syndrome. Fertil. Steril., 57, 1117-1120.
23. Scott, R. T., Bailey, S. A., Kost, E. R., Neal, G. S., Hofmann, G. E. and Illions, E. H. (1994) Comparison of leuprolide acetate and human chorionic gonadotropin for the induction of ovulation in clomiphene citrate-stimulated cycles. Fertil. Steril., 61, 872-879.
24. Segal, S. and Casper, R.F. (1992) Gonadotropin-releasing hormone agonist versus human chorionic gonadotropin for triggering follicular maturation in in vitro fertilization. Fertil. Steril., 57, 1254-1258.
25. Smitz, J., Devroey, P., Faguer, B., Bourgain, C., Camus, M. and Van Steirteghem, A.C. (1992) A prospective randomized comparison of intramuscular or intravaginal natural progesterone as a luteal phase and early pregnancy supplement. Hum. Reprod., 7, 168-175.
26. van der Meer, S., Gerris, J., Joostens, M. and Tas, B. (1993) Triggering of ovulation using a gonadotrophin-releasing hormone agonist does not prevent ovarian hyperstimulation syndrome. Hum. Reprod., 8, 1628-1631.
27. Van Weissenbruch, M.M., Schoemaker, H.C., Drexhage, H.A. and Schoemaker, J. (1993) Pharmacodynamics of human menopausal gonadotrophin (HMG) and follicle-stimulating hormone (FSH). The importance of the FSH concentration in initiating follicular growth in polycystic ovary-like disease. Hum. Reprod., 6, 813-821.
28. Verhelst, J., Gerris, J., Joostens, M., van der Meer, S., Van Royen, E. and Mahler, C. (1993) Clinical and endocrine effects of laser vaporization in patients with polycystic ovarian disease. Int. J. Gynecol. Endocrinol., 7, 49-55.
29. Yen, S.C.C., Llerena, O., Little, B. and Pearson, O.H. (1968) Disappearance rates of endogeneous luteinizing hormone and chorionic gonadotropins in man. J. Clin. Endocrinol., 28, 1763-1767.